New Delhi, Feb. 4 -- Emcure Pharmaceuticals is tapping influencers and celebrities on social media, in addition to raising awareness among doctors, for its semaglutide brand, Poviztra, as it seeks to ... Read More
MUMBAI, Feb. 3 -- India's push to become a global hub for drug development faces a basic constraint: the country does not have enough standardized, trial-ready hospitals and clinics to scale up to mee... Read More
New Delhi, Feb. 3 -- Mankind Pharma's net profit climbed 9.5% in the third quarter, missing estimates, as revenue increased, driven by domestic growth and consolidation of Bharat Serums and Vaccines L... Read More
New Delhi, Jan. 31 -- The Mumbai-based drugmaker said its total sales rose 15.1% year-on-year to Rs.15,469 crore. Total revenue from operations rose 13.4% YoY to Rs.15,520.5 crore, the company said in... Read More
New Delhi, Jan. 30 -- Sun Pharma, India's largest drugmaker, is set to post its results for the third quarter of the fiscal year on Saturday. While brokerages anticipate steady domestic growth and mar... Read More
New Delhi, Jan. 29 -- Piramal Pharma Ltd is starting to see early signs of a recovery in its contract manufacturing business, with order inflows picking up on the back of improved biopharma funding an... Read More
New Delhi, Jan. 27 -- India's landmark free trade deal with the European Union, finalised on Tuesday, includes significant tariff cuts on exports of pharmaceutical products as well as optical, medical... Read More
New Delhi, Jan. 25 -- The US has formally withdrawn from the World Health Organization (WHO), a year after President Donald Trump signed an executive order to begin the process. The move deprives the... Read More
New Delhi, Jan. 24 -- Sun Pharmaceutical Industries Ltd has received the Drugs Controller General of India's (DCGI) approval to make and market a generic version of semaglutide injection for weight ma... Read More
Mumbai, Jan. 23 -- Contract drug research and manufacturing firm Syngene International Ltd has lowered its full-year revenue guidance from mid-single digit growth to negative 2-3%, as destocking of a ... Read More